VCNX
Vaccinex Inc
Halal Rating :
Last Price
$1.42
Last updated:
Market Cap
-
7D Change
-61.23%
1 Year Change
92.52%
Company Overview
Industries
Exchange
Next Earnings Date
Vaccinex, Inc. is a clinical-stage biotechnology company focused on the development of innovative treatments for cancer and neurodegenerative diseases. The company's primary technology platform, ActivMAb, is used to create antibody candidates for various therapeutic applications. Their lead product candidate, pepinemab, is being studied for the treatment of various cancers and Huntington's disease.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $52000.0 | $4.6m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $232000.0 | $5.95m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $104000.0 | $5.18m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Vaccinex Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.